Drug Profile
Interferon beta-1a biosimilar - Biosidus
Alternative Names: Biosidus interferon beta 1a; BlastoferonLatest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator Biosidus S.A.
- Class Antiasthmatics; Antineoplastics; Antivirals; Interferons; Vascular disorder therapies
- Mechanism of Action Interferon beta stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Multiple sclerosis
Most Recent Events
- 10 Aug 2011 Launched for Multiple sclerosis in Argentina (Parenteral)
- 16 May 2011 Launched for Multiple sclerosis in Chile (Parenteral)